{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:39:07Z","timestamp":1788993547480,"version":"build-2803163510"},"reference-count":224,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T00:00:00Z","timestamp":1516492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Two primary causes of respiratory tract infections are respiratory syncytial virus (RSV) and influenza viruses, both of which remain major public health concerns. There are a limited number of antiviral drugs available for the treatment of RSV and influenza, each having limited effectiveness and each driving selective pressure for the emergence of drug-resistant viruses. Novel broad-spectrum antivirals are needed to circumvent problems with current disease intervention strategies, while improving the cytokine-induced immunopathology associated with RSV and influenza infections. In this review, we examine the use of Verdinexor (KPT-335, a novel orally bioavailable drug that functions as a selective inhibitor of nuclear export, SINE), as an antiviral with multifaceted therapeutic potential. KPT-335 works to (1) block CRM1 (i.e., Chromosome Region Maintenance 1; exportin 1 or XPO1) mediated export of viral proteins critical for RSV and influenza pathogenesis; and (2) repress nuclear factor \u03baB (NF-\u03baB) activation, thus reducing cytokine production and eliminating virus-associated immunopathology. The repurposing of SINE compounds as antivirals shows promise not only against RSV and influenza virus but also against other viruses that exploit the nucleus as part of their viral life cycle.<\/jats:p>","DOI":"10.3390\/v10010048","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T04:51:13Z","timestamp":1516596673000},"page":"48","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses"],"prefix":"10.3390","volume":"10","author":[{"given":"Jennifer","family":"Pickens","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-9956","authenticated-orcid":false,"given":"Ralph","family":"Tripp","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,1,21]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2016). Influenza (Seasonal) Factsheet n\u00b0 12, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"ref_3","first-page":"5593","article-title":"Clinical aspects and cytokine response in adults with seasonal influenza infection","volume":"7","author":"Bian","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(05)70270-X","article-title":"Understanding the symptoms of the common cold and influenza","volume":"5","author":"Eccles","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1586\/14760584.7.2.249","article-title":"Influenza and respiratory syncytial virus in the elderly","volume":"7","author":"Elliot","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"Hall","year":"2013","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1542\/peds.113.6.1758","article-title":"Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children","volume":"113","author":"Iwane","year":"2004","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002512-200522070-00004","article-title":"Respiratory syncytial virus infection in elderly adults","volume":"22","author":"Falsey","year":"2005","journal-title":"Drugs Aging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virol.2017.04.001","article-title":"Inhibition of CRM1-mediated nuclear export of influenza a nucleoprotein and nuclear export protein as a novel target for antiviral drug development","volume":"507","author":"Chutiwitoonchai","year":"2017","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/JVI.02374-08","article-title":"The respiratory syncytial virus matrix protein possesses a CRM1-mediated nuclear export mechanism","volume":"83","author":"Ghildyal","year":"2009","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1093\/emboj\/19.24.6751","article-title":"Influenza a virus NS2 protein mediates VRNP nuclear export through NES-independent interaction with HCRM1","volume":"19","author":"Neumann","year":"2000","journal-title":"EMBO J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1128\/JVI.01774-14","article-title":"Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo","volume":"88","author":"Perwitasari","year":"2014","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/j.1460-2075.1986.tb04506.x","article-title":"Nuclear location of all three influenza polymerase proteins and a nuclear signal in polymerase PB2","volume":"5","author":"Jones","year":"1986","journal-title":"EMBO J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrmicro3367","article-title":"At the centre: Influenza A virus ribonucleoproteins","volume":"13","author":"Eisfeld","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1128\/jvi.71.12.9690-9700.1997","article-title":"Nuclear import and export of influenza virus nucleoprotein","volume":"71","author":"Neumann","year":"1997","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"22701","DOI":"10.1074\/jbc.270.39.22701","article-title":"Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import","volume":"270","author":"Jaskunas","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_19","first-page":"359","article-title":"Evolution and ecology of influenza A viruses","volume":"385","author":"Yoon","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11","volume":"22","author":"Wu","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/304076a0","article-title":"Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity","volume":"304","author":"Rogers","year":"1983","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0042-6822(83)90507-X","article-title":"Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: Selection of receptor specific variants","volume":"131","author":"Rogers","year":"1983","journal-title":"Virology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/viro.2001.0833","article-title":"Nuclear export of influenza virus ribonucleoproteins: Identification of an export intermediate at the nuclear periphery","volume":"282","author":"Ma","year":"2001","journal-title":"Virology"},{"key":"ref_25","first-page":"1","article-title":"Viral entry","volume":"285","author":"Sieczkarski","year":"2005","journal-title":"Curr. Top. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev.cellbio.16.1.627","article-title":"Viral entry into the nucleus","volume":"16","author":"Whittaker","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0006-3495(96)79690-X","article-title":"Ion selectivity and activation of the M2 ion channel of influenza virus","volume":"70","author":"Shimbo","year":"1996","journal-title":"Biophys. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0006-3495(95)80003-2","article-title":"Activation of the M2 ion channel of influenza virus: A role for the transmembrane domain histidine residue","volume":"69","author":"Wang","year":"1995","journal-title":"Biophys. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1073\/pnas.92.14.6532","article-title":"Mammalian karyopherin \u03b11\u03b2 and \u03b12\u03b2 heterodimers: \u03b11 or \u03b12 subunit binds nuclear localization signal and \u03b2 subunit interacts with peptide repeat-containing nucleoporins","volume":"92","author":"Moroianu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1073\/pnas.92.5.1769","article-title":"Identification of a protein complex that is required for nuclear protein import and mediates docking of import substrate to distinct nucleoporins","volume":"92","author":"Radu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/0022-1317-75-1-29","article-title":"Complex structure of the nuclear translocation signal of influenza virus polymerase PAa subunit","volume":"75","author":"Nieto","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/jvi.61.7.2217-2224.1987","article-title":"Intracellular localization of the viral polymerase proteins in cells infected with influenza virus and cells expressing PB1 protein from cloned cDNA","volume":"61","author":"Akkina","year":"1987","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/JVI.75.1.408-419.2001","article-title":"Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway","volume":"75","author":"Elton","year":"2001","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0092-8674(91)90576-K","article-title":"Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import","volume":"67","author":"Martin","year":"1991","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/JVI.74.4.1781-1786.2000","article-title":"Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins","volume":"74","author":"Bui","year":"2000","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1099\/jgv.0.000959","article-title":"ICTV virus taxonomy profile: Pneumoviridae","volume":"98","author":"Rima","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/viro.1993.1366","article-title":"Cytoplasmic inclusions of respiratory syncytial virus-infected cells: Formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein","volume":"195","author":"Garcia","year":"1993","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1128\/JVI.00343-08","article-title":"Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein","volume":"82","author":"Li","year":"2008","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.1073\/pnas.260499197","article-title":"Structural characterization of the human respiratory syncytial virus fusion protein core","volume":"97","author":"Zhao","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/jvi.68.7.4538-4546.1994","article-title":"The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons","volume":"68","author":"Roberts","year":"1994","journal-title":"J. Virol."},{"key":"ref_42","first-page":"371","article-title":"Human airway epithelial cell cultures for modeling respiratory syncytial virus infection","volume":"372","author":"Pickles","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/JVI.76.11.5654-5666.2002","article-title":"Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology","volume":"76","author":"Zhang","year":"2002","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1073\/pnas.1110203109","article-title":"In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo","volume":"109","author":"Villenave","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fmb.09.1","article-title":"The host response and molecular pathogenesis associated with respiratory syncytial virus infection","volume":"4","author":"Oshansky","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1128\/JVI.06274-11","article-title":"Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells","volume":"86","author":"Reyes","year":"2012","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm.2444","article-title":"Identification of nucleolin as a cellular receptor for human respiratory syncytial virus","volume":"17","author":"Tayyari","year":"2011","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00705-003-0112-y","article-title":"The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription","volume":"148","author":"Ghildyal","year":"2003","journal-title":"Arch. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1099\/0022-1317-83-4-753","article-title":"Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells","volume":"83","author":"Ghildyal","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1021\/bi050701e","article-title":"Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin \u03b21 independent of importin \u03b1","volume":"44","author":"Ghildyal","year":"2005","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"Schnell","year":"2008","journal-title":"Nature"},{"key":"ref_52","unstructured":"Centers for Disease Control and Prevention (CDC) (2017). Influenza Antiviral Drug Resistance Fact Sheet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2009.05.066","article-title":"Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus","volume":"385","author":"Rungrotmongkol","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"Wu","year":"1993","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: Antiviral action and mechanisms of resistance","volume":"7","year":"2013","journal-title":"Influenza Respir. Viruses"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"ref_58","first-page":"v","article-title":"A potent and selective inhibitor of influenza A and B viruses","volume":"36","author":"Aoki","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","article-title":"Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza","volume":"341","author":"Hayden","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment","volume":"282","author":"Hayden","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00430-002-0139-9","article-title":"Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment","volume":"191","author":"Gillissen","year":"2002","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1098\/rstb.2001.1008","article-title":"Influenza diagnosis and treatment: A view from clinical practice","volume":"356","author":"Fleming","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00063030-200115050-00003","article-title":"Prophylaxis and treatment of influenza virus infection","volume":"15","author":"Kandel","year":"2001","journal-title":"BioDrugs"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1714916","article-title":"Chasing seasonal influenza\u2014The need for a universal influenza vaccine","volume":"378","author":"Paules","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.45.10.2723-2732.2001","article-title":"Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses","volume":"45","author":"Govorkova","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fmicb.2016.00450","article-title":"Peramivir: A novel intravenous neuraminidase inhibitor for treatment of acute influenza infections","volume":"7","author":"Alame","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/AAC.06456-11","article-title":"Intrapulmonary distribution and pharmacokinetics of laninamivir, a neuraminidase inhibitor, after a single inhaled administration of its prodrug, laninamivir octanoate, in healthy volunteers","volume":"56","author":"Ishizuka","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s10156-013-0622-9","article-title":"Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: A randomized double blind placebo controlled trial","volume":"19","author":"Kashiwagi","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/AAC.01311-09","article-title":"Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration","volume":"54","author":"Kubo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1358\/dof.2010.35.7.1510471","article-title":"Laninamivir octanoate neuraminidase inhibitor treatment of influenza","volume":"35","author":"Reviriego","year":"2010","journal-title":"Drugs Future"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/AAC.03313-14","article-title":"Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir","volume":"58","author":"Samson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/656802","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial","volume":"51","author":"Watanabe","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Tricco, A.C., Chit, A., Soobiah, C., Hallett, D., Meier, G., Chen, M.H., Tashkandi, M., Bauch, C.T., and Loeb, M. (2013). Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-analysis. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-153"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e00018-10","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","first-page":"14","article-title":"Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus","volume":"47","year":"1997","journal-title":"An. Espan. Pediatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/clinids\/12.6.1139","article-title":"Molecular mechanisms of action of ribavirin","volume":"12","author":"Patterson","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/adc.64.3.425","article-title":"Ribavirin in respiratory syncytial virus infection","volume":"64","author":"Sharland","year":"1989","journal-title":"Arch. Dis. Child."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1128\/AAC.00932-15","article-title":"Baseline polymorphisms and emergence of drug resistance in the NS3\/4A protease of hepatitis c virus genotype 1 following treatment with faldaprevir and pegylated interferon \u03b1 2a\/Ribavirin in phase 2 and phase 3 studies","volume":"59","author":"Berger","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S979","DOI":"10.1016\/S0016-5085(14)63558-7","article-title":"Drug resistance mutations in the NS3 and NS5A regions in patients with hepatitis C virus genotype 1B and response to telaprevir plus pegylated-interferon-\u03b1 2B and ribavirin combination therapy","volume":"146","author":"Hayashi","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1086\/653534","article-title":"Palivizumab-resistant human respiratory syncytial virus infection in infancy","volume":"51","author":"Adams","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.09.014","article-title":"Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery","volume":"127","author":"Heylen","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.93.6.1239","article-title":"Ribavirin aerosol in the elderly","volume":"93","author":"Liss","year":"1988","journal-title":"Chest"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMe1407467","article-title":"Progress in the prevention and treatment of RSV infection","volume":"371","author":"Wright","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S2213-2600(15)00255-6","article-title":"Lower respiratory tract infection caused by respiratory syncytial virus: Current management and new therapeutics","volume":"3","author":"Mazur","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaci.2017.07.001","article-title":"Promising approaches for the treatment and prevention of viral respiratory illnesses","volume":"140","author":"Papadopoulos","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12979-017-0090-7","article-title":"Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults","volume":"14","author":"Fries","year":"2017","journal-title":"Immun. Ageing"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.vaccine.2012.11.009","article-title":"Safety and immunogenicity of a SF9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine","volume":"31","author":"Glenn","year":"2013","journal-title":"Vaccine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2017.03.015","article-title":"Ongoing developments in RSV prophylaxis: A clinician\u2019s analysis","volume":"24","author":"Rezaee","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"E3441","DOI":"10.1073\/pnas.1405198111","article-title":"Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors","volume":"111","author":"Yan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.antiviral.2014.12.012","article-title":"Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen","volume":"115","author":"Laganas","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s41061-017-0129-4","article-title":"Recent advances in developing antiviral therapies for respiratory syncytial virus","volume":"375","author":"Shook","year":"2017","journal-title":"Top. Curr. Chem. (Cham)"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/17476348.2017.1338567","article-title":"Respiratory syncytial virus: Prospects for new and emerging therapeutics","volume":"11","author":"Jorquera","year":"2017","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/jm5017768","article-title":"Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study","volume":"58","author":"Mackman","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/AAC.01497-15","article-title":"GS-5806 inhibits a broad range of respiratory syncytial virus clinical isolates by blocking the virus-cell fusion process","volume":"60","author":"Perron","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1128\/AAC.00761-15","article-title":"GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein","volume":"59","author":"Samuel","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2003.09.008","article-title":"Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus","volume":"61","author":"Kimura","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(00)00091-7","article-title":"Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo","volume":"47","author":"Kimura","year":"2000","journal-title":"Antivir. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.04119-14","article-title":"Mechanism of action for respiratory syncytial virus inhibitor RSV604","volume":"59","author":"Challa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.49.6.2460-2466.2005","article-title":"Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms","volume":"49","author":"Douglas","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/JVI.77.9.5054-5064.2003","article-title":"Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with f protein","volume":"77","author":"Douglas","year":"2003","journal-title":"J. Virol."},{"key":"ref_111","first-page":"425","article-title":"VP-14637 viropharma","volume":"1","year":"2000","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1128\/JVI.00530-15","article-title":"Respiratory syncytial virus inhibitor AZ-27 differentially inhibits different polymerase activities at the promoter","volume":"89","author":"Noton","year":"2015","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMc1516110","article-title":"ALS-008176 for respiratory syncytial virus infection","volume":"374","author":"DeVincenzo","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMoa1413275","article-title":"Activity of oral ALS-008176 in a respiratory syncytial virus challenge study","volume":"373","author":"DeVincenzo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: A first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: A double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Jin, Z., Smith, L.K., Rajwanshi, V.K., Kim, B., and Deval, J. (2013). The ambiguous base-pairing and high substrate efficiency of T-705 (favipiravir) ribofuranosyl 5\u2032-triphosphate towards influenza A virus polymerase. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068347"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.bmcl.2015.03.013","article-title":"Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors","volume":"25","author":"Boyd","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1073\/pnas.1013592107","article-title":"High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.03123-12","article-title":"Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-RAB11 complexes in influenza A virus infection","volume":"87","author":"Amorim","year":"2013","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"29684","DOI":"10.1038\/srep29684","article-title":"Structural characterization of H1N1 nucleoprotein-nucleozin binding sites","volume":"6","author":"Pang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Triana-Baltzer, G.B., Gubareva, L.V., Klimov, A.I., Wurtman, D.F., Moss, R.B., Hedlund, M., Larson, J.L., Belshe, R.B., and Fang, F. (2009). Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007838"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Triana-Baltzer, G.B., Gubareva, L.V., Nicholls, J.M., Pearce, M.B., Mishin, V.P., Belser, J.A., Chen, L.M., Chan, R.W., Chan, M.C., and Hedlund, M. (2009). Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007788"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e00218-12","DOI":"10.1128\/mBio.00218-12","article-title":"Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2","volume":"3","author":"Rallabhandi","year":"2012","journal-title":"mBio"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist eritoran protects mice from lethal influenza infection","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/eri.11.56","article-title":"Immunomodulatory therapy for severe influenza","volume":"9","author":"Darwish","year":"2011","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","article-title":"The inflammatory response triggered by influenza virus: A two edged sword","volume":"66","author":"Tavares","year":"2017","journal-title":"Inflamm. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"R203","DOI":"10.1186\/cc9324","article-title":"Clinical aspects and cytokine response in severe H1N1 influenza A virus infection","volume":"14","author":"Hagau","year":"2010","journal-title":"Crit. Care"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/650581","article-title":"Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection","volume":"50","author":"To","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1186\/cc8208","article-title":"Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza","volume":"13","author":"Pumarola","year":"2009","journal-title":"Crit. Care"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/rccm.200909-1420OC","article-title":"Lung pathology in fatal novel human influenza A (H1N1) infection","volume":"181","author":"Mauad","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archpedi.1995.02170200048006","article-title":"Relationship of infant feeding to recurrent wheezing at age 6 years","volume":"149","author":"Wright","year":"1995","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.micinf.2012.11.012","article-title":"Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response","volume":"15","author":"Lay","year":"2013","journal-title":"Microbes Infect."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/vim.2004.17.370","article-title":"Respiratory syncytial virus-induced immunoprotection and immunopathology","volume":"17","author":"Durbin","year":"2004","journal-title":"Viral Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/0882824041310513","article-title":"Pathogenesis of respiratory syncytial virus infection","volume":"17","author":"Tripp","year":"2004","journal-title":"Viral Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2009.121582","article-title":"Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life","volume":"65","author":"Sigurs","year":"2010","journal-title":"Thorax"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: Balancing virus clearance and immunopathology","volume":"38","author":"Newton","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"Openshaw","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fimmu.2015.00361","article-title":"Modulating the innate immune response to influenza A virus: Potential therapeutic use of anti-inflammatory drugs","volume":"6","author":"Ramos","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_146","first-page":"139","article-title":"Innate immune responses to respiratory syncytial virus infection","volume":"372","author":"Mukherjee","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00726-009-0374-0","article-title":"Induction of type I interferon by RNA viruses: Cellular receptors and their substrates","volume":"38","author":"Baum","year":"2010","journal-title":"Amino Acids"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jb\/mvm032","article-title":"Antiviral signaling through pattern recognition receptors","volume":"141","author":"Kawai","year":"2007","journal-title":"J. Biochem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.4049\/jimmunol.179.7.4711","article-title":"Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination","volume":"179","author":"Koyama","year":"2007","journal-title":"J. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00441-010-1017-1","article-title":"Insights into the role of toll-like receptors in modulation of T cell responses","volume":"343","author":"Kulkarni","year":"2011","journal-title":"Cell Tissue Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1165\/rcmb.2003-0388OC","article-title":"Activation of airway epithelial cells by toll-like receptor agonists","volume":"31","author":"Sha","year":"2004","journal-title":"Am. J. Respir. Cell Mol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.1324266111","article-title":"Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"53035","DOI":"10.1074\/jbc.M308093200","article-title":"Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin","volume":"278","author":"Monick","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1203\/PDR.0b013e318191f5c6","article-title":"Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway","volume":"65","author":"Xie","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1128\/JVI.03370-13","article-title":"Mechanisms of RIG-I-Like receptor activation and manipulation by viral pathogens","volume":"88","author":"Gack","year":"2014","journal-title":"J. Virol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2010.01.020","article-title":"RIG-I detects viral genomic RNA during negative-strand RNA virus infection","volume":"140","author":"Rehwinkel","year":"2010","journal-title":"Cell"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.09.039","article-title":"Structural basis for the activation of innate immune pattern-recognition receptor RIG-Ii by viral RNA","volume":"147","author":"Kowalinski","year":"2011","journal-title":"Cell"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.immuni.2009.03.011","article-title":"Fighting the flu with inflammasome signaling","volume":"30","author":"Owen","year":"2009","journal-title":"Immunity"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Pothlichet, J., Meunier, I., Davis, B.K., Ting, J.P., Skamene, E., von Messling, V., and Vidal, S.M. (2013). Type I IFN triggers RIG-I\/TLR3\/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003256"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: Guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/thoraxjnl-2012-202182","article-title":"Human respiratory syncytial virus viroporin SH: A viral recognition pathway used by the host to signal inflammasome activation","volume":"68","author":"Triantafilou","year":"2013","journal-title":"Thorax"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"McAuley, J.L., Tate, M.D., MacKenzie-Kludas, C.J., Pinar, A., Zeng, W., Stutz, A., Latz, E., Brown, L.E., and Mansell, A. (2013). Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003392"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by NOD2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1128\/JVI.01110-14","article-title":"Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T cell responses to influenza A virus infection","volume":"88","author":"Lupfer","year":"2014","journal-title":"J. Virol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.4049\/jimmunol.178.6.3368","article-title":"Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells","volume":"178","author":"Pothlichet","year":"2007","journal-title":"J. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Le Goffic, R., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M., and Si-Tahar, M. (2006). Detrimental contribution of the toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020053"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.4049\/jimmunol.176.3.1733","article-title":"Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells","volume":"176","author":"Groskreutz","year":"2006","journal-title":"J. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/JVI.79.6.3350-3357.2005","article-title":"Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression","volume":"79","author":"Rudd","year":"2005","journal-title":"J. Virol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/pats.200502-014AW","article-title":"Cytokines and respiratory syncytial virus infection","volume":"2","author":"Tripp","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N","article-title":"Pathology of fatal human infection associated with avian influenza a H5N1 virus","volume":"63","author":"To","year":"2001","journal-title":"J. Med. Virol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1034\/j.1399-3038.1999.101005.x","article-title":"Macrophage inflammatory protein-1\u03b1 and RANTES are present in nasal secretions during ongoing upper respiratory tract infection","volume":"10","author":"Bonville","year":"1999","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/CMR.00054-07","article-title":"Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma","volume":"21","author":"Mohapatra","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"D59","DOI":"10.1016\/j.vaccine.2008.07.025","article-title":"Pathology of human influenza revisited","volume":"26","author":"Kuiken","year":"2008","journal-title":"Vaccine"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"495848","DOI":"10.1155\/2013\/495848","article-title":"IL-1\u03b2 and IL-6 upregulation in children with H1N1 influenza virus infection","volume":"2013","author":"Chiaretti","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Yu, X., Zhang, X., Zhao, B., Wang, J., Zhu, Z., Teng, Z., Shao, J., Shen, J., Gao, Y., and Yuan, Z. (2011). Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028680"},{"key":"ref_182","unstructured":"Knipe, D.M., and Howley, P.M. (2013). Fields Virology, Wolters Kluwer\/Lippincott Williams and Wilkins Health. [6th ed.]."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1128\/JVI.02581-06","article-title":"Multiple anti-interferon actions of the influenza A virus NS1 protein","volume":"81","author":"Kochs","year":"2007","journal-title":"J. Virol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1128\/JVI.76.21.11166-11171.2002","article-title":"The influenza a virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors","volume":"76","author":"Ludwig","year":"2002","journal-title":"J. Virol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/JVI.01265-06","article-title":"Inhibition of retinoic acid-inducible gene I-mediated induction of \u03b2 interferon by the NS1 protein of influenza A virus","volume":"81","author":"Mibayashi","year":"2007","journal-title":"J. Virol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0042-6822(02)00127-7","article-title":"Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3\u2032 end processing of cellular pre-mRNAs","volume":"307","author":"Noah","year":"2003","journal-title":"Virology"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.78.12.6705.2004","article-title":"Suppression of the induction of \u03b1, \u03b2, and \u03bb interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages","volume":"78","author":"Spann","year":"2004","journal-title":"J. Virol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1128\/JVI.00715-09","article-title":"Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways","volume":"83","author":"Swedan","year":"2009","journal-title":"J. Virol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"738547","DOI":"10.1155\/2015\/738547","article-title":"Respiratory syncytial virus nonstructural proteins upregulate SOCS1 and SOCS3 in the different manner from endogenous IFN signaling","volume":"2015","author":"Zheng","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/vim.2008.0098","article-title":"Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway","volume":"22","author":"Oshansky","year":"2009","journal-title":"Viral Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.1128\/JVI.01162-12","article-title":"The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement","volume":"86","author":"Bukreyev","year":"2012","journal-title":"J. Virol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1128\/JVI.01604-08","article-title":"The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on fc receptor-bearing leukocytes","volume":"82","author":"Bukreyev","year":"2008","journal-title":"J. Virol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice","volume":"84","author":"Zhang","year":"2010","journal-title":"J. Virol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1073\/pnas.0409478102","article-title":"The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin","volume":"102","author":"Polack","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3389\/fmicb.2017.01171","article-title":"CRM1 inhibitors for antiviral therapy","volume":"8","author":"Mathew","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jb\/mvg197","article-title":"Cellular requirements for CRM1 import and export","volume":"134","author":"Zhang","year":"2003","journal-title":"J. Biochem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/cells4030538","article-title":"Structural basis of targeting the exportin CRM1 in cancer","volume":"4","author":"Dickmanns","year":"2015","journal-title":"Cells"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semcancer.2014.03.001","article-title":"Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents","volume":"27","author":"Turner","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.cellbio.15.1.607","article-title":"Transport between the cell nucleus and the cytoplasm","volume":"15","author":"Gorlich","year":"1999","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00418-007-0371-x","article-title":"Towards reconciling structure and function in the nuclear pore complex","volume":"129","author":"Lim","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1083\/jcb.110.4.883","article-title":"Correlation between structure and mass distribution of the nuclear pore complex and of distinct pore complex components","volume":"110","author":"Reichelt","year":"1990","journal-title":"J. Cell Biol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.biochem.67.1.265","article-title":"Nucleocytoplasmic transport: The soluble phase","volume":"67","author":"Mattaj","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.03.002","article-title":"Atomic basis of CRM1-cargo recognition, release and inhibition","volume":"27","author":"Fung","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1091\/mbc.e12-01-0045","article-title":"NESdb: A database of NES-containing CRM1 cargoes","volume":"23","author":"Xu","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0092-8674(00)80371-2","article-title":"CRM1 is an export receptor for leucine-rich nuclear export signals","volume":"90","author":"Fornerod","year":"1997","journal-title":"Cell"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/36894","article-title":"CRM1 is responsible for intracellular transport mediated by the nuclear export signal","volume":"390","author":"Fukuda","year":"1997","journal-title":"Nature"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1586","article-title":"Structural basis for assembly and disassembly of the CRM1 nuclear export complex","volume":"16","author":"Dong","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature07975","article-title":"Structural basis for leucine-rich nuclear export signal recognition by CRM1","volume":"458","author":"Dong","year":"2009","journal-title":"Nature"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.1173388","article-title":"Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP","volume":"324","author":"Monecke","year":"2009","journal-title":"Science"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Breit, M.N., Kisseberth, W.C., Bear, M.D., Landesman, Y., Kashyap, T., McCauley, D., Kauffman, M.G., Shacham, S., and London, C.A. (2014). Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines. BMC Vet. Res., 10.","DOI":"10.1186\/1746-6148-10-160"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-014-0067-3","article-title":"SINE (selective inhibitor of nuclear export)\u2014Translational science in a new class of anti-cancer agents","volume":"7","author":"Gerecitano","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/vco.12289","article-title":"In vitro evaluation of selective inhibitors of nuclear export (SINE) drugs KPT-185 and KPT-335 against canine mammary carcinoma and transitional cell carcinoma tumor initiating cells","volume":"15","author":"Grayton","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canlet.2016.09.016","article-title":"Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone","volume":"383","author":"Muqbil","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/bjc.1996.415","article-title":"Phase I trial of elactocin","volume":"74","author":"Newlands","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1006\/excr.1998.4136","article-title":"Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1","volume":"242","author":"Kudo","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/leu.2012.219","article-title":"Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells","volume":"27","author":"Etchin","year":"2013","journal-title":"Leukemia"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Perwitasari, O., Johnson, S., Yan, X., Register, E., Crabtree, J., Gabbard, J., Howerth, E., Shacham, S., Carlson, R., and Tamir, S. (2016). Antiviral efficacy of verdinexor in vivo in two animal models of influenza A virus infection. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167221"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"London, C.A., Bernabe, L.F., Barnard, S., Kisseberth, W.C., Borgatti, A., Henson, M., Wilson, H., Jensen, K., Ito, D., and Modiano, J.F. (2014). Preclinical evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 in spontaneous canine cancer: Results of a phase I study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087585"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.97.3.1014","article-title":"A nuclear export signal in the N-terminal regulatory domain of IkB\u03b1 controls cytoplasmic localization of inactive NF-\u03baB\/IkB\u03b1 complexes","volume":"97","author":"Huang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1128\/MCB.20.6.2269-2284.2000","article-title":"Cytoplasmic sequestration of Rel proteins by IkB\u03b1 requires CRM1-dependent nuclear export","volume":"20","author":"Tam","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/MCB.15.5.2689","article-title":"Inducible nuclear expression of newly synthesized IkB\u03b1 negatively regulates DNA-binding and transcriptional activities of NF-\u03baB","volume":"15","author":"Thompson","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1242\/jcs.110.3.369","article-title":"Nuclear localization of i\u03baB\u03b1 promotes active transport of NF-\u03baB from the nucleus to the cytoplasm","volume":"110","author":"Turpin","year":"1997","journal-title":"J. Cell Sci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"15193","DOI":"10.1074\/jbc.275.20.15193","article-title":"Inducible NF-\u03baB activation is permitted by simultaneous degradation of nuclear I\u03baB\u03b1","volume":"275","author":"Renard","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/1\/48\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:52:03Z","timestamp":1760194323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/1\/48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,21]]},"references-count":224,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["v10010048"],"URL":"https:\/\/doi.org\/10.3390\/v10010048","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,21]]}}}